RxDoctor Payments Data

Elissa Malkin

Family Medicine · Washington, DCNPI 1285194977

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $2,500 of the $2,500 with a category attached, or 100.0%. Every reported general payment came from a single manufacturer, Novavax Inc. Among family medicine clinicians in DC with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$2,500in general payments, 2019–2025

Across 2 payments — averaging $1250.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novavax Inc$3K
$570,700in research payments, 2019–2025

Across 46 payments — averaging $12,407 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Pfizer$569K
  • Novavax Inc$1K

What the payments were for

  • Consulting fees$2,500100%

General payments by program year

23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Novavax Inc2$2,500

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,500 in reported general payments places this provider in the 90th percentile of 166 family medicine providers in District of Columbia.

See all family medicine providers in District of Columbia

Other family medicine in Washington

See the full list for District of Columbia

Where these figures come from

Is this you, or does something look wrong? →